Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Herald's Sam McKewon and Evan Bland preview Nebraska's spring football and talk transfer player draft in this episode of Pick Six. The World-Herald's Meet The Transfers feature returns to spotlight ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する